Vaccines Conference Speakers

The Vaccine Development Conference has over 22 industry leaders addressing your key development challenges.

Presenting the 2009 conference speaking faculty:

• Keynote Presentation: Vaccinology: A Vaccines Historical Perspective and the Potential Impact on the Vaccines Business by Arthur Allen, Author, Vaccine: the Controversial Story of Medicine’s Greatest Lifesaver
• Byeong Chang, President and Chief Scientific Officer, Integrity Bio
• Dexiang Chen, PhD, Senior Technical Officer, Program for Appropriate Technology in Health (PATH)
• Dr. Jeff Drew, PhD, Chief Scientific Officer, Stabilitech Ltd.
• Nathalie Garcon, PharmD, PhD, Vice President, Head of Global Adjuvant Center, GlaxoSmithKline Biologicals
• James L. Gulley, M.D., Ph.D., F.A.C.P., Director, Clinical Trials Group, Laboratory of Tumor Immunology and Biology, CCR, National Cancer Institute, NIH
• Dennis M. Klinman, MD/PhD, Senior Investigator, Cancer and Inflammation Program, National Cancer Institute, NIH
• Hedwig Kresse, Senior Analyst, Infectious Diseases, Datamonitor
• Franck Lemiale, PhD, PharmD, Director, Vaccines & Immunology, VIRxSYS Corporation
• Marc Mansour, PhD, VP R&D, ImmunoVaccine Technologies Inc. (IVT)
• John B March, PhD, CEO and Chief Scientific Officer, BigDNA
• Hersh Mehta, PhD, Head, Product Conception and Development, Sanofi-Pasteur
• Mark R. Prausnitz, PhD, Professor of Chemical and Biomedical Engineering, Georgia Institute of Technology
• Richard M. Schwartz, PhD, Chief, Vaccine Production Program, Vaccine Research Center, NIAID, NIH
• Alain Rolland, PharmD, PhD, Senior Vice President, Product Development, Vical Incorporated
• Scott Winston, PhD, Aktiv-Dry LLC
• Robert Simler, PhD, Staff Scientist II, Genzyme Corporation
• Vu Truong-Le, Vice President of R&D, Aridis Pharma
• Vincent Turula, Wyeth Vaccines
• Marli Watts, MD, CSL Limited
• Darin Lee Zehrung, Technical Officer, Program for Appropriate Technology in Health (PATH)